Skip to main content
Top
Published in: International Urology and Nephrology 2/2024

30-09-2023 | Kidney Cancer | Urology - Original Paper

Clear cell renal cell carcinoma cells show diffuse expression of phagocytotic markers through the identification of lysosome-rich eosinophilic granules

Authors: Vasudevan D. Mahalingam, Oumaima S. Chaib, Hassan D. Kanaan, Jason M. Hafron, Ping L. Zhang

Published in: International Urology and Nephrology | Issue 2/2024

Login to get access

Abstract

Background

Paneth cell-like granules (PCLG) in clear cell renal cell carcinomas (RCC) have previously been reported but were not found to express neuroendocrine markers. This study was to investigate if the eosinophilic granules (so called PCLG) were enlarged lysosomes.

Methods

A retrospective review of 72 different renal tumors was conducted which included 42 clear cell RCC, 16 papillary RCC, 6 chromophobe RCC, 5 clear cell papillary RCC, 2 urothelial carcinomas and 1 unclassified RCC. All tumors were evaluated for the eosinophilic granules on hematoxylin and eosin-stained sections. In addition, PAS-D staining, immunohistochemical stains, and electron microscopy were performed.

Results

The eosinophilic granules were found in 19% (8 out of 42) clear cell RCC, but not in the other renal tumor types. The granules stained positively for PAS-D and were also positive for lysosomal protein markers CD68 and lysozyme. Electron microscopy revealed that the eosinophilic granules were smooth ball-shaped structures in the cytoplasm, ranging in size from 0.8 to 1.4 µm. The overall findings indicate that the eosinophilic granules were best correlated with lysosomes.

Conclusions

The eosinophilic granules in clear cell RCC are expanded lysosomes, and this may be used as a unique feature for confirming the pathologic diagnosis of clear cell RCC. The findings further support the view that clear cell RCC have phagocytic capacity due to their containing abundant lysosomes in the cytoplasm.
Literature
1.
go back to reference Broussy J, Barry J (1948) Notes on the characters and significance of Paneth cells. Toulouse Med 49(12):815–821PubMed Broussy J, Barry J (1948) Notes on the characters and significance of Paneth cells. Toulouse Med 49(12):815–821PubMed
2.
go back to reference Behnke O, Moe H (1964) An electron microscope study of mature and differentiating Paneth cells in the rat, especially of their endoplasmic reticulum and lysosomes. J Cell Biol 22:633–652CrossRefPubMedPubMedCentral Behnke O, Moe H (1964) An electron microscope study of mature and differentiating Paneth cells in the rat, especially of their endoplasmic reticulum and lysosomes. J Cell Biol 22:633–652CrossRefPubMedPubMedCentral
3.
go back to reference Matsubara F (1977) Morphological study of the Paneth cell. Paneth cells in intestinal metaplasia of the stomach and duodenum of man. Acta Pathol Jpn 27(5):677–695PubMed Matsubara F (1977) Morphological study of the Paneth cell. Paneth cells in intestinal metaplasia of the stomach and duodenum of man. Acta Pathol Jpn 27(5):677–695PubMed
4.
go back to reference Shi J (2007) Defensins and Paneth cells in inflammatory bowel disease. Inflamm Bowel Dis 13(10):1284–1292CrossRefPubMed Shi J (2007) Defensins and Paneth cells in inflammatory bowel disease. Inflamm Bowel Dis 13(10):1284–1292CrossRefPubMed
5.
go back to reference Azzopardi JG, Hou LT (1965) Intestinal metaplasia with argentaffin cells in cervical adenocarcinoma. J Pathol Bacteriol 90(2):686–690CrossRefPubMed Azzopardi JG, Hou LT (1965) Intestinal metaplasia with argentaffin cells in cervical adenocarcinoma. J Pathol Bacteriol 90(2):686–690CrossRefPubMed
6.
go back to reference Lee KR, Trainer TD (1990) Adenocarcinoma of the uterine cervix of small intestinal type containing numerous Paneth cells. Arch Pathol Lab Med 114(7):731–733PubMed Lee KR, Trainer TD (1990) Adenocarcinoma of the uterine cervix of small intestinal type containing numerous Paneth cells. Arch Pathol Lab Med 114(7):731–733PubMed
7.
go back to reference Pallesen G (1981) Neoplastic Paneth cells in adenocarcinoma of the urinary bladder: a first case report. Cancer 47(7):1834–1837CrossRefPubMed Pallesen G (1981) Neoplastic Paneth cells in adenocarcinoma of the urinary bladder: a first case report. Cancer 47(7):1834–1837CrossRefPubMed
8.
go back to reference Haratake J, Horie A, Ito K (1987) Argyrophilic adenocarcinoma of the prostate with Paneth cell-like granules. Acta Pathol Jpn 37(5):831–836PubMed Haratake J, Horie A, Ito K (1987) Argyrophilic adenocarcinoma of the prostate with Paneth cell-like granules. Acta Pathol Jpn 37(5):831–836PubMed
9.
go back to reference Frydman CP, Bleiweiss IJ, Unger PD, Gordon RE, Brazenas NV (1992) Paneth cell-like metaplasia of the prostate gland. Arch Pathol Lab Med 116(3):274–276PubMed Frydman CP, Bleiweiss IJ, Unger PD, Gordon RE, Brazenas NV (1992) Paneth cell-like metaplasia of the prostate gland. Arch Pathol Lab Med 116(3):274–276PubMed
10.
go back to reference Weaver MG, Abdul-Karim FW, Srigley J, Bostwick DG, Ro JY, Ayala AG (1992) Paneth cell-like change of the prostate gland. A histological, immunohistochemical, and electron microscopic study. Am J Surg Pathol 16(1):62–68CrossRefPubMed Weaver MG, Abdul-Karim FW, Srigley J, Bostwick DG, Ro JY, Ayala AG (1992) Paneth cell-like change of the prostate gland. A histological, immunohistochemical, and electron microscopic study. Am J Surg Pathol 16(1):62–68CrossRefPubMed
11.
go back to reference Adlakha H, Bostwick DG (1994) Paneth cell-like change in prostatic adenocarcinoma represents neuroendocrine differentiation: report of 30 cases. Hum Pathol 25(2):135–139CrossRefPubMed Adlakha H, Bostwick DG (1994) Paneth cell-like change in prostatic adenocarcinoma represents neuroendocrine differentiation: report of 30 cases. Hum Pathol 25(2):135–139CrossRefPubMed
12.
go back to reference Shah VI, Ro JY, Amin MB, Mullick S, Nazeer T, Ayala AG (1998) Histologic variations in the epididymis: findings in 167 orchiectomy specimens. Am J Surg Pathol 22(8):990–996CrossRefPubMed Shah VI, Ro JY, Amin MB, Mullick S, Nazeer T, Ayala AG (1998) Histologic variations in the epididymis: findings in 167 orchiectomy specimens. Am J Surg Pathol 22(8):990–996CrossRefPubMed
13.
go back to reference Krishnan B, Truong LD (2002) Renal epithelial neoplasms: the diagnostic implications of electron microscopic study in 55 cases. Hum Pathol 33(1):68–79CrossRefPubMed Krishnan B, Truong LD (2002) Renal epithelial neoplasms: the diagnostic implications of electron microscopic study in 55 cases. Hum Pathol 33(1):68–79CrossRefPubMed
14.
go back to reference Kojima F, Bulimbasic S, Alaghehbandan R, Martinek P, Vanecek T, Michalova K, Pivovarcikova K, Michal M, Hora M, Murata SI, Sugawara E, Rogala J, Limani R, Hes O (2019) Clear cell renal cell carcinoma with Paneth-like cells: clinicopathologic, morphologic, immunohistochemical, ultrastructural, and molecular analysis of 13 cases. Ann Diagn Pathol 41:96–101CrossRefPubMed Kojima F, Bulimbasic S, Alaghehbandan R, Martinek P, Vanecek T, Michalova K, Pivovarcikova K, Michal M, Hora M, Murata SI, Sugawara E, Rogala J, Limani R, Hes O (2019) Clear cell renal cell carcinoma with Paneth-like cells: clinicopathologic, morphologic, immunohistochemical, ultrastructural, and molecular analysis of 13 cases. Ann Diagn Pathol 41:96–101CrossRefPubMed
15.
go back to reference Zhang PL, Mashni JW, Sabbisetti VS, Schworer CM, Wilson GD, Wolforth SC, Kernen KM, Seifman BD, Amin MB, Geddes TJ, Lin F, Bonventre JV, Hafron JM (2014) Urine kidney injury molecule-1: a potential non-invasive biomarker for patients with renal cell carcinoma. Int Urol Nephrol 46(2):379–388CrossRefPubMed Zhang PL, Mashni JW, Sabbisetti VS, Schworer CM, Wilson GD, Wolforth SC, Kernen KM, Seifman BD, Amin MB, Geddes TJ, Lin F, Bonventre JV, Hafron JM (2014) Urine kidney injury molecule-1: a potential non-invasive biomarker for patients with renal cell carcinoma. Int Urol Nephrol 46(2):379–388CrossRefPubMed
16.
go back to reference Heitz PU, Wegmann W (1980) Identification of neoplastic Paneth cells in an adenocarcinoma of the stomach using lysozyme as a marker, and electron microscopy. Virchows Arch A Pathol Anat Histol 386(1):107–116CrossRefPubMed Heitz PU, Wegmann W (1980) Identification of neoplastic Paneth cells in an adenocarcinoma of the stomach using lysozyme as a marker, and electron microscopy. Virchows Arch A Pathol Anat Histol 386(1):107–116CrossRefPubMed
17.
go back to reference Holness CL, Simmons DL (1993) Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. Blood 81(6):1607–1613CrossRefPubMed Holness CL, Simmons DL (1993) Molecular cloning of CD68, a human macrophage marker related to lysosomal glycoproteins. Blood 81(6):1607–1613CrossRefPubMed
18.
go back to reference Callerio-Babudieri D (1966) Lysozyme granules and lysosome structures in cell culture. Nature 212(5067):1274–1275CrossRefPubMed Callerio-Babudieri D (1966) Lysozyme granules and lysosome structures in cell culture. Nature 212(5067):1274–1275CrossRefPubMed
19.
go back to reference Morrissey JJ, London AN, Lambert MC, Kharasch ED (2011) Sensitivity and specificity of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 for the diagnosis of renal cell carcinoma. Am J Nephrol 34(5):391–398CrossRefPubMed Morrissey JJ, London AN, Lambert MC, Kharasch ED (2011) Sensitivity and specificity of urinary neutrophil gelatinase-associated lipocalin and kidney injury molecule-1 for the diagnosis of renal cell carcinoma. Am J Nephrol 34(5):391–398CrossRefPubMed
20.
go back to reference Mijuskovic M, Stanojevic I, Milovic N, Cerovic S, Petrovic D, Maksic D, Kovacevic B, Andjelic T, Aleksic P, Terzic B, Djukic M, Vojvodic D (2018) Tissue and urinary KIM-1 relate to tumor characteristics in patients with clear renal cell carcinoma. Int Urol Nephrol 50(1):63–70CrossRefPubMed Mijuskovic M, Stanojevic I, Milovic N, Cerovic S, Petrovic D, Maksic D, Kovacevic B, Andjelic T, Aleksic P, Terzic B, Djukic M, Vojvodic D (2018) Tissue and urinary KIM-1 relate to tumor characteristics in patients with clear renal cell carcinoma. Int Urol Nephrol 50(1):63–70CrossRefPubMed
21.
go back to reference Scelo G, Muller DC, Riboli E, Johansson M, Cross AJ, Vineis P, Tsilidis KK, Brennan P, Boeing H, Peeters PHM, Vermeulen RCH, Overvad K, Bueno-de-Mesquita HB, Severi G, Perduca V, Kvaskoff M, Trichopoulou A, La Vecchia C, Karakatsani A, Palli D, Sieri S, Panico S, Weiderpass E, Sandanger TM, Nost TH, Agudo A, Quiros JR, Rodriguez-Barranco M, Chirlaque MD, Key TJ, Khanna P, Bonventre JV, Sabbisetti VS, Bhatt RS (2018) KIM-1 as a blood-based marker for early detection of kidney cancer: a prospective nested case–control study. Clin Cancer Res 24(22):5594–5601CrossRefPubMedPubMedCentral Scelo G, Muller DC, Riboli E, Johansson M, Cross AJ, Vineis P, Tsilidis KK, Brennan P, Boeing H, Peeters PHM, Vermeulen RCH, Overvad K, Bueno-de-Mesquita HB, Severi G, Perduca V, Kvaskoff M, Trichopoulou A, La Vecchia C, Karakatsani A, Palli D, Sieri S, Panico S, Weiderpass E, Sandanger TM, Nost TH, Agudo A, Quiros JR, Rodriguez-Barranco M, Chirlaque MD, Key TJ, Khanna P, Bonventre JV, Sabbisetti VS, Bhatt RS (2018) KIM-1 as a blood-based marker for early detection of kidney cancer: a prospective nested case–control study. Clin Cancer Res 24(22):5594–5601CrossRefPubMedPubMedCentral
22.
go back to reference Zhang KJ, Wilson GD, Kara S, Majeske A, Zhang PL, Hafron JM (2019) Diagnostic role of kidney injury molecule-1 in renal cell carcinoma. Int Urol Nephrol 51(11):1893–1902CrossRefPubMed Zhang KJ, Wilson GD, Kara S, Majeske A, Zhang PL, Hafron JM (2019) Diagnostic role of kidney injury molecule-1 in renal cell carcinoma. Int Urol Nephrol 51(11):1893–1902CrossRefPubMed
Metadata
Title
Clear cell renal cell carcinoma cells show diffuse expression of phagocytotic markers through the identification of lysosome-rich eosinophilic granules
Authors
Vasudevan D. Mahalingam
Oumaima S. Chaib
Hassan D. Kanaan
Jason M. Hafron
Ping L. Zhang
Publication date
30-09-2023
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 2/2024
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-023-03809-5

Other articles of this Issue 2/2024

International Urology and Nephrology 2/2024 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.